Business Description
TherapeuticsMD Inc
NAICS : 325412
SIC : 2834
ISIN : US88338N1072
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.54 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -1.05 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -30.18 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -78 | |||||
3-Year EBITDA Growth Rate | 70.3 | |||||
3-Year EPS without NRI Growth Rate | 71.9 | |||||
3-Year FCF Growth Rate | 57.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 4.53 | |||||
9-Day RSI | 14.56 | |||||
14-Day RSI | 23.81 | |||||
6-1 Month Momentum % | -3.56 | |||||
12-1 Month Momentum % | -36.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.72 | |||||
Quick Ratio | 1.72 | |||||
Cash Ratio | 0.63 | |||||
Days Sales Outstanding | 9014.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.4 | |||||
Shareholder Yield % | 447.48 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -654.61 | |||||
Net Margin % | -789.4 | |||||
FCF Margin % | -1772.73 | |||||
ROE % | -33.01 | |||||
ROA % | -17.27 | |||||
ROIC % | -19.46 | |||||
ROC (Joel Greenblatt) % | -117.28 | |||||
ROCE % | -21.78 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 15.15 | |||||
PB Ratio | 0.75 | |||||
Price-to-Tangible-Book | 0.95 | |||||
EV-to-EBIT | -2.98 | |||||
EV-to-EBITDA | -3.34 | |||||
EV-to-Revenue | 19.48 | |||||
EV-to-Forward-Revenue | 0.95 | |||||
EV-to-FCF | -1.1 | |||||
Earnings Yield (Greenblatt) % | -33.56 | |||||
FCF Yield % | -104.79 | |||||
Forward Rate of Return (Yacktman) % | 23332.95 |